Explore more publications!
Colorado Health Reporter
Got News to Share?

Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 2, 2026

Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
Apr. 2, 2026

Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Indeterminate GlobeNewswire
Visory Health se posiciona entre las principales tarjetas de descuento para medicamentos bajo prescripción en Estados Unidos, ofreciendo a millones de personas acceso a tratamientos asequibles
Apr. 2, 2026

Visory Health se posiciona entre las principales tarjetas de descuento para medicamentos bajo prescripción en Estados Unidos, ofreciendo a millones de personas acceso a tratamientos asequibles

Indeterminate GlobeNewswire
Get Summer-Season Ready with New Notorious Fitness Training Plans
Apr. 2, 2026

Get Summer-Season Ready with New Notorious Fitness Training Plans

Indeterminate GlobeNewswire
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
Apr. 2, 2026

MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

Indeterminate GlobeNewswire
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
Apr. 2, 2026

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

Indeterminate GlobeNewswire
GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société  
Apr. 2, 2026

GENFIT : Résultats financiers annuels 2025 et point sur les activités de la Société  

Indeterminate GlobeNewswire
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update  
Apr. 2, 2026

GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update  

Indeterminate GlobeNewswire
Medicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Support 
Apr. 2, 2026

Medicana Health Group Marks World Autism Awareness Day with a Call for Inclusion, Earlier Recognition and Family-Centered Support 

Indeterminate GlobeNewswire
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
Apr. 2, 2026

EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire
Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month
Apr. 2, 2026

Liv Hospital Highlights Hospital-Based Stem Cell Infrastructure During Autism Awareness Month

Indeterminate GlobeNewswire
Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic Preparedness
Apr. 2, 2026

Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic Preparedness

Indeterminate GlobeNewswire
AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026
Apr. 2, 2026

AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026

Indeterminate GlobeNewswire
Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026
Apr. 2, 2026

Le programme de bourses d'études MII d’AbbVie fête ses 15 ans : les candidatures sont ouvertes pour 2026

Indeterminate GlobeNewswire
Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030 | MarketsandMarkets™
Apr. 2, 2026

Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire
Paul Markovich Discusses Healthcare Reform Through the Worthy Movement on YourUpdateTV
Apr. 2, 2026

Paul Markovich Discusses Healthcare Reform Through the Worthy Movement on YourUpdateTV

Indeterminate GlobeNewswire
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
Apr. 2, 2026

BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure

Indeterminate GlobeNewswire
Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications
Apr. 2, 2026

Visory Health Ranks Among Top U.S. Prescription Cards Providing Millions of Americans Access to Affordable Medications

Indeterminate GlobeNewswire
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide
Apr. 2, 2026

Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide

Indeterminate GlobeNewswire
GeneProof Announces CMV IVDR Launch on the myCROBE™ Fully Automated System for Transplant Care
Apr. 2, 2026

GeneProof Announces CMV IVDR Launch on the myCROBE™ Fully Automated System for Transplant Care

Indeterminate GlobeNewswire
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
Apr. 2, 2026

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions